ZNF480
gene geneOn this page
Also known as MGC32104
Summary
ZNF480 (zinc finger protein 480, HGNC:23305) is a protein-coding gene on chromosome 19q13.41, encoding Zinc finger protein 480 (Q8WV37). Involved in transcriptional regulation as an activator.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in cytosol and nucleoplasm.
Source: NCBI Gene 147657 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 78 total
- MANE Select transcript:
NM_144684
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23305 |
| Approved symbol | ZNF480 |
| Name | zinc finger protein 480 |
| Location | 19q13.41 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC32104 |
| Ensembl gene | ENSG00000198464 |
| Ensembl biotype | protein_coding |
| OMIM | 613910 |
| Entrez | 147657 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 11 protein_coding, 1 nonsense_mediated_decay
ENST00000334564, ENST00000335090, ENST00000468240, ENST00000490272, ENST00000595962, ENST00000598016, ENST00000852522, ENST00000852523, ENST00000852524, ENST00000944566, ENST00000944567, ENST00000944568
RefSeq mRNA: 4 — MANE Select: NM_144684
NM_001297624, NM_001297625, NM_001412109, NM_144684
CCDS: CCDS12850, CCDS74437, CCDS77346
Canonical transcript exons
ENST00000595962 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002501787 | 52314153 | 52314279 |
| ENSE00003147865 | 52321579 | 52325922 |
| ENSE00003612625 | 52315834 | 52315962 |
| ENSE00003660758 | 52300394 | 52300484 |
| ENSE00003844712 | 52297169 | 52297223 |
Expression profiles
Bgee: expression breadth ubiquitous, 166 present calls, max score 86.39.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.5428 / max 107.3570, expressed in 1502 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177297 | 4.5428 | 1502 |
Top tissues by expression
281 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 86.39 | gold quality |
| calcaneal tendon | UBERON:0003701 | 85.65 | gold quality |
| apex of heart | UBERON:0002098 | 85.26 | gold quality |
| islet of Langerhans | UBERON:0000006 | 84.98 | gold quality |
| right atrium auricular region | UBERON:0006631 | 84.66 | gold quality |
| monocyte | CL:0000576 | 84.17 | gold quality |
| leukocyte | CL:0000738 | 83.94 | gold quality |
| gastrocnemius | UBERON:0001388 | 83.90 | gold quality |
| mononuclear cell | CL:0000842 | 83.86 | gold quality |
| muscle of leg | UBERON:0001383 | 83.30 | gold quality |
| heart left ventricle | UBERON:0002084 | 82.75 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 82.56 | gold quality |
| ganglionic eminence | UBERON:0004023 | 82.14 | gold quality |
| cortical plate | UBERON:0005343 | 81.83 | gold quality |
| lower esophagus | UBERON:0013473 | 81.83 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 81.83 | gold quality |
| cardiac atrium | UBERON:0002081 | 81.65 | gold quality |
| cardiac ventricle | UBERON:0002082 | 81.36 | gold quality |
| rectum | UBERON:0001052 | 81.11 | gold quality |
| colonic epithelium | UBERON:0000397 | 81.04 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 80.95 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 80.34 | gold quality |
| left adrenal gland | UBERON:0001234 | 80.21 | gold quality |
| heart | UBERON:0000948 | 79.76 | gold quality |
| body of stomach | UBERON:0001161 | 79.72 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 79.64 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 79.59 | gold quality |
| esophagus | UBERON:0001043 | 79.38 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 79.22 | gold quality |
| right adrenal gland | UBERON:0001233 | 79.11 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.55 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets.
| Target | Regulation |
|---|---|
| AP1 |
miRNA regulators (miRDB)
110 targeting ZNF480, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-3134 | 100.00 | 66.43 | 777 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-7152-3P | 99.97 | 67.47 | 849 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-6753-3P | 99.93 | 66.57 | 637 |
| HSA-MIR-7107-3P | 99.93 | 66.73 | 627 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-12133 | 99.92 | 71.82 | 2006 |
| HSA-MIR-1271-5P | 99.91 | 71.99 | 1972 |
| HSA-MIR-6499-3P | 99.90 | 66.38 | 1212 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-8062 | 99.88 | 68.43 | 995 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-7978 | 99.86 | 66.90 | 856 |
| HSA-MIR-659-3P | 99.85 | 70.69 | 1620 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
| HSA-MIR-6844 | 99.82 | 70.69 | 2423 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-4799-5P | 99.82 | 70.60 | 2663 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
Literature-anchored findings (GeneRIF, showing 1)
- This supports the notion that de novo mutations in ZNF480 are extremely rare in schizophrenia (PMID:23425335)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zfx | ENSDARG00000074453 |
| danio_rerio | ENSDARG00000098424 | |
| mus_musculus | Zfy2 | ENSMUSG00000000103 |
| mus_musculus | Zfy1 | ENSMUSG00000053211 |
| rattus_norvegicus | Zfy1 | ENSRNOG00000053042 |
Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF691 (ENSG00000164011), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZNF584 (ENSG00000171574), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF793 (ENSG00000188227), ZNF548 (ENSG00000188785), ZNF79 (ENSG00000196152), ZNF418 (ENSG00000196724), ZNF772 (ENSG00000197128), ZNF583 (ENSG00000198440), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)
Protein
Protein identifiers
Zinc finger protein 480 — Q8WV37 (reviewed: Q8WV37)
All UniProt accessions (4): Q8WV37, C9IZQ0, F8WEZ9, M0R367
UniProt curated annotations — full annotation on UniProt →
Function. Involved in transcriptional regulation as an activator.
Subcellular location. Nucleus.
Tissue specificity. Expressed in fetal heart, heart, skeletal muscle, pancreas and placenta.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8WV37-1 | 1 | yes |
| Q8WV37-2 | 2 | |
| Q8WV37-3 | 3 |
RefSeq proteins (4): NP_001284553, NP_001284554, NP_001399038, NP_653285* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13465
UniProt features (22 total): zinc finger region 12, cross-link 4, splice variant 2, sequence variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WV37-F1 | 70.95 | 0.35 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (4): 122, 125, 195, 220
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 57 (showing top):
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP, KRAS.AMP.LUNG_UP.V1_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, NAB2_TARGET_GENES, ZNF350_TARGET_GENES, MIR335_3P, MIR6885_3P, MIR511_5P, MIR4762_3P, MIR6830_5P, MIR6516_5P, MIR6505_5P, MIR3925_3P, MIR5571_5P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (4): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytosol (GO:0005829), nuclear lumen (GO:0031981)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| cellular anatomical structure | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| nucleus | 1 |
| intracellular organelle lumen | 1 |
Protein interactions and networks
STRING
416 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF480 | PRR19 | A6NJB7 | 397 |
| ZNF480 | KRTAP5-10 | Q6L8G5 | 380 |
| ZNF480 | GIPC3 | Q8TF64 | 380 |
| ZNF480 | ALS2CL | Q60I27 | 368 |
| ZNF480 | VSIG10L | Q86VR7 | 358 |
| ZNF480 | GPATCH4 | Q5T3I0 | 308 |
| ZNF480 | FBXW12 | Q6X9E4 | 301 |
| ZNF480 | USP17L17 | D6RBQ6 | 297 |
| ZNF480 | DEFB126 | Q9BYW3 | 277 |
| ZNF480 | ALDH16A1 | Q8IZ83 | 275 |
| ZNF480 | NGRN | Q9NPE2 | 270 |
| ZNF480 | PLEKHA6 | Q9Y2H5 | 269 |
| ZNF480 | SLC2A4RG | Q9NR83 | 254 |
| ZNF480 | DNTTIP2 | Q5QJE6 | 250 |
| ZNF480 | TMBIM1 | Q969X1 | 248 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CCNDBP1 | ZNF480 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF480 | KDM1A | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF480 | IPO8 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF467 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| NOTCH2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| LTBP2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| CUL9 | NVL | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF480 | CCNDBP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (11): ZNF480 (Two-hybrid), ZNF480 (Affinity Capture-MS), ZNF480 (Affinity Capture-MS), ZNF480 (Affinity Capture-MS), ZNF480 (Affinity Capture-MS), ZNF480 (Affinity Capture-MS), ZNF480 (Affinity Capture-MS), ZNF480 (Affinity Capture-MS), ZNF480 (Protein-RNA), ZNF480 (Affinity Capture-RNA), KDM1A (Two-hybrid)
ESM2 similar proteins: A2RRD8, A6NHJ4, B4DX44, O75346, P10077, P10755, P15621, P16372, P16373, P51786, P52737, P85977, Q0VGE8, Q14588, Q147U1, Q15928, Q15973, Q2M3X9, Q3KNS6, Q3MIS6, Q494X3, Q5HY98, Q5RBQ3, Q5REK1, Q5VIY5, Q60585, Q61751, Q6GQR8, Q7L2R6, Q7TSH9, Q8IYX0, Q8N782, Q8N823, Q8N988, Q8N9F8, Q8NA42, Q8NCK3, Q8NDP4, Q8NEP9, Q8TC21
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
78 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 62 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1351 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:52297219:GGCGC:G | donor_gain | 0.9900 |
| 19:52297220:GCGC:G | donor_gain | 0.9900 |
| 19:52297220:GCGCG:G | donor_gain | 0.9900 |
| 19:52297222:GC:G | donor_gain | 0.9900 |
| 19:52297224:G:GG | donor_gain | 0.9900 |
| 19:52299347:A:AG | donor_gain | 0.9900 |
| 19:52300306:GG:G | donor_gain | 0.9900 |
| 19:52300307:GG:G | donor_gain | 0.9900 |
| 19:52315828:A:AG | acceptor_gain | 0.9900 |
| 19:52315829:A:G | acceptor_gain | 0.9900 |
| 19:52315829:AACAG:A | acceptor_loss | 0.9900 |
| 19:52315830:ACAG:A | acceptor_loss | 0.9900 |
| 19:52315831:CAGGA:C | acceptor_loss | 0.9900 |
| 19:52315832:A:AG | acceptor_gain | 0.9900 |
| 19:52315833:G:GA | acceptor_loss | 0.9900 |
| 19:52315833:G:GG | acceptor_gain | 0.9900 |
| 19:52315833:GGA:G | acceptor_gain | 0.9900 |
| 19:52315958:CACAG:C | donor_loss | 0.9900 |
| 19:52315959:ACAG:A | donor_loss | 0.9900 |
| 19:52315960:CAGGT:C | donor_loss | 0.9900 |
| 19:52315962:GGTAA:G | donor_loss | 0.9900 |
| 19:52315963:GTAA:G | donor_loss | 0.9900 |
| 19:52315964:T:A | donor_loss | 0.9900 |
| 19:52297221:CGC:C | donor_gain | 0.9800 |
| 19:52297221:CGCG:C | donor_loss | 0.9800 |
| 19:52297222:GCG:G | donor_gain | 0.9800 |
| 19:52297223:CGT:C | donor_loss | 0.9800 |
| 19:52297224:G:GA | donor_loss | 0.9800 |
| 19:52297225:TGA:T | donor_loss | 0.9800 |
| 19:52297226:G:GT | donor_loss | 0.9800 |
AlphaMissense
3565 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:52322640:T:C | F464L | 0.995 |
| 19:52322642:C:A | F464L | 0.995 |
| 19:52322642:C:G | F464L | 0.995 |
| 19:52322724:T:C | F492L | 0.995 |
| 19:52322726:C:A | F492L | 0.995 |
| 19:52322726:C:G | F492L | 0.995 |
| 19:52322808:T:C | F520L | 0.990 |
| 19:52322810:T:A | F520L | 0.990 |
| 19:52322810:T:G | F520L | 0.990 |
| 19:52322669:T:A | H473Q | 0.988 |
| 19:52322669:T:G | H473Q | 0.988 |
| 19:52322731:G:C | R494P | 0.986 |
| 19:52322667:C:G | H473D | 0.985 |
| 19:52322472:T:C | F408L | 0.984 |
| 19:52322474:T:A | F408L | 0.984 |
| 19:52322474:T:G | F408L | 0.984 |
| 19:52322556:T:C | F436L | 0.984 |
| 19:52322558:T:A | F436L | 0.984 |
| 19:52322558:T:G | F436L | 0.984 |
| 19:52322681:T:A | H477Q | 0.984 |
| 19:52322681:T:G | H477Q | 0.984 |
| 19:52322671:A:C | Q474P | 0.982 |
| 19:52322429:T:A | H393Q | 0.981 |
| 19:52322429:T:G | H393Q | 0.981 |
| 19:52322659:T:C | L470P | 0.981 |
| 19:52322641:T:C | F464S | 0.980 |
| 19:52322753:T:A | H501Q | 0.980 |
| 19:52322753:T:G | H501Q | 0.980 |
| 19:52322667:C:A | H473N | 0.979 |
| 19:52314186:T:C | F36L | 0.978 |
dbSNP variants (sampled 300 via entrez): RS1000004859 (19:52313983 A>C), RS1000078366 (19:52312479 G>T), RS1000101457 (19:52320071 C>G), RS1000219687 (19:52309354 A>G), RS1000254206 (19:52296985 C>G,T), RS1000434555 (19:52302949 C>G,T), RS1000438241 (19:52313699 A>G), RS1000540829 (19:52298686 G>A), RS1000739234 (19:52310475 ATTTTT>A,ATTT,ATTTT,ATTTTTT,ATTTTTTT,ATTTTTTTTTTTTTTTTTTT), RS1000807273 (19:52303136 C>A,G,T), RS1001144550 (19:52299227 T>C,G), RS1001252276 (19:52309202 C>T), RS1001253671 (19:52295356 G>T), RS1001273608 (19:52303199 C>T), RS1001641493 (19:52303478 A>G)
Disease associations
OMIM: gene MIM:613910 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | affects cotreatment, increases abundance, increases oxidation, affects expression | 2 |
| Benzo(a)pyrene | affects methylation, decreases expression | 2 |
| Ozone | increases oxidation, increases abundance, affects expression, affects cotreatment | 2 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| dicrotophos | decreases expression | 1 |
| geldanamycin | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| alpha-pinene | affects cotreatment, increases oxidation, increases abundance | 1 |
| methacrylaldehyde | affects cotreatment, increases oxidation, increases abundance | 1 |
| bisphenol S | decreases methylation | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| NSC668394 | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Acrolein | affects cotreatment, increases oxidation, increases abundance | 1 |
| Clorgyline | increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Endosulfan | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Zinc | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Volatile Organic Compounds | affects cotreatment, increases oxidation | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A8I0 | SEES3-1V human ZNF480, clone1 | Embryonic stem cell | Male |
| CVCL_A8I1 | SEES3-1V human ZNF480, clone2 | Embryonic stem cell | Male |
| CVCL_A8I2 | SEES3-1V human ZNF480, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.